Log in

NASDAQ:IOSP - Innospec Stock Price, Forecast & News

$66.56
-6.79 (-9.26 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$66.21
Now: $66.56
$72.31
50-Day Range
$61.37
MA: $85.43
$104.74
52-Week Range
$56.71
Now: $66.56
$107.85
Volume150,043 shs
Average Volume177,224 shs
Market Capitalization$1.63 billion
P/E Ratio14.63
Dividend Yield1.42%
Beta1.28
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and metal extraction markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and asset integrity. The Octane Additives segment produces and sells tetra ethyl lead (TEL) for use in automotive gasoline. This segment is also involved in environmental remediation business that manages the cleanup of redundant TEL facilities. The company sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction preparations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Read More
Innospec logo

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Current SymbolNASDAQ:IOSP
CUSIP45768S10
Phone303-792-5554

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.51 billion
Cash Flow$6.54 per share
Book Value$37.51 per share

Profitability

Net Income$112.20 million

Miscellaneous

Employees2,000
Market Cap$1.63 billion
Next Earnings Date5/5/2020 (Estimated)
OptionableOptionable

Receive IOSP News and Ratings via Email

Sign-up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.


Innospec (NASDAQ:IOSP) Frequently Asked Questions

How has Innospec's stock been impacted by COVID-19 (Coronavirus)?

Innospec's stock was trading at $72.47 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IOSP stock has decreased by 8.2% and is now trading at $66.56. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Innospec?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Innospec.

When is Innospec's next earnings date?

Innospec is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Innospec.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) posted its quarterly earnings data on Tuesday, February, 18th. The specialty chemicals company reported $1.47 EPS for the quarter, topping the consensus estimate of $1.38 by $0.09. The specialty chemicals company earned $390.70 million during the quarter, compared to the consensus estimate of $400.45 million. Innospec had a net margin of 7.41% and a return on equity of 14.69%. The company's revenue was down 1.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.62 earnings per share. View Innospec's earnings history.

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec announced a Semi-Annual dividend on Tuesday, November 5th. Stockholders of record on Tuesday, November 19th will be given a dividend of $0.52 per share on Wednesday, November 27th. The ex-dividend date of this dividend is Monday, November 18th. This is an increase from Innospec's previous Semi-Annual dividend of $0.50. View Innospec's dividend history.

What price target have analysts set for IOSP?

1 brokers have issued 12 month target prices for Innospec's stock. Their forecasts range from $95.00 to $95.00. On average, they expect Innospec's stock price to reach $95.00 in the next year. This suggests a possible upside of 42.7% from the stock's current price. View analysts' price targets for Innospec.

Has Innospec been receiving favorable news coverage?

News coverage about IOSP stock has trended extremely negative this week, according to InfoTrie. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Innospec earned a media sentiment score of -5.0 on InfoTrie's scale. They also gave headlines about the specialty chemicals company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutInnospec.

Are investors shorting Innospec?

Innospec saw a decrease in short interest in March. As of March 13th, there was short interest totaling 510,100 shares, a decrease of 14.0% from the February 27th total of 593,000 shares. Based on an average daily trading volume, of 157,000 shares, the days-to-cover ratio is currently 3.2 days. Currently, 2.1% of the company's shares are sold short. View Innospec's Current Options Chain.

Who are some of Innospec's key competitors?

What other stocks do shareholders of Innospec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include Intellia Therapeutics (NTLA), Las Vegas Sands (LVS), Altria Group (MO), Exxon Mobil (XOM), NVIDIA (NVDA), Franklin Resources (BEN), Colgate-Palmolive (CL), Eastman Chemical (EMN), Emerson Electric (EMR) and Invesco (IVZ).

Who are Innospec's key executives?

Innospec's management team includes the following people:
  • Mr. Patrick S. Williams, Pres, CEO & Director (Age 54)
  • Mr. Ian P. Cleminson, Exec. VP & CFO (Age 53)
  • Dr. Philip J. Boon, COO & Exec. VP (Age 60)
  • Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 70)
  • Mr. Brian R. Watt, Sr. VP of Corp. Devel. & Investor Relations (Age 60)

What is Innospec's stock symbol?

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

Who are Innospec's major shareholders?

Innospec's stock is owned by a number of retail and institutional investors. Top institutional shareholders include FMR LLC (11.72%), State Street Corp (2.90%), Champlain Investment Partners LLC (2.71%), Royce & Associates LP (2.42%), Geode Capital Management LLC (1.47%) and Nuveen Asset Management LLC (1.39%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View institutional ownership trends for Innospec.

Which institutional investors are selling Innospec stock?

IOSP stock was sold by a variety of institutional investors in the last quarter, including Jacobs Levy Equity Management Inc., Goldman Sachs Group Inc., First Wilshire Securities Management Inc., NWQ Investment Management Company LLC, Bank of New York Mellon Corp, Royce & Associates LP, Westwood Holdings Group Inc., and SG Americas Securities LLC. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, Hugh Aldous, Ian Cleminson, Philip Curran, and Philip John Boon. View insider buying and selling activity for Innospec.

Which institutional investors are buying Innospec stock?

IOSP stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, FMR LLC, James Investment Research Inc., Thrivent Financial for Lutherans, Great West Life Assurance Co. Can, Bank of Montreal Can, Citigroup Inc., and Mackay Shields LLC. View insider buying and selling activity for Innospec.

How do I buy shares of Innospec?

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Innospec's stock price today?

One share of IOSP stock can currently be purchased for approximately $66.56.

How big of a company is Innospec?

Innospec has a market capitalization of $1.63 billion and generates $1.51 billion in revenue each year. Innospec employs 2,000 workers across the globe. View additional information about Innospec.

What is Innospec's official website?

The official website for Innospec is http://www.innospecinc.com/.

How can I contact Innospec?

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]


MarketBeat Community Rating for Innospec (NASDAQ IOSP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  297 (Vote Outperform)
Underperform Votes:  295 (Vote Underperform)
Total Votes:  592
MarketBeat's community ratings are surveys of what our community members think about Innospec and other stocks. Vote "Outperform" if you believe IOSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IOSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel